Outcomes in Patients Resuming Intravitreal Anti-VEGF Therapy Following Treatment Delay during the COVID-19 Pandemic. Rush RB, Rush SW. Retina 2021 Aug 2. pii: 00006982-900000000-95424.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rush RB, Rush SW. Outcomes in Patients Resuming Intravitreal Anti-VEGF Therapy Following Treatment Delay during the COVID-19 Pandemic. Retina 2021 Aug 2. pii: 00006982-900000000-95424.
PMID: 34369441